15/05/2025
Lunatus Launches Visulac Line in Riyadh, Saudi Arabia
We proudly introduced the Visulac line during the scientific conference “Beyond Tears: Understanding the Inflammatory Roots of Dry Eye Disease”, held on April 22nd at Narcissus The Royal Hotel, Riyadh.
Chairperson: Dr. Abdulmajed Othman Aljaethen, Consultant in Cornea Transplant, Cataract Extraction, Secondary IOLs, and Refractive Surgery including LASIK and PRK, led the event alongside guest speaker Prof. Stefano Barabino, Head of Ocular Surface & Dry Eye Service at Università di Milano and a global authority in dry eye disease.
The event brought together leading ophthalmologists to explore inflammation as a key factor in dry eye disease.
Now available in Saudi Arabia:
🔹 Visulac HA 0.4% COMBI – A paradigm shift towards the treatment of moderate to severe evaporative dry eye disease associated with blepharitis. Presented as a preservative-free, sterile eye drop, uniquely formulated with Hyaluronic Acid 0.4%, Castor Oil, Levocarnitine, and Zinc to deliver comprehensive relief by hydrating, nourishing, and protecting the eyes—safe for frequent use without the risk of preservative-related side effects.
🔹 Visulac HA 0.2% SDU – A preservative-free eye drop presented in single dose units containing high-quality Sodium Hyaluronate 0.2% that provides lasting relief from dry eye symptoms. It is ideal for use with all types of contact lenses and for soothing dryness caused by a reduced or altered aqueous layer, especially post-LASIK surgery.
🔹 Visugel PLUS – A sterile eye gel uniquely formulated with Dexpanthenol 5% + Carbomer 0.3% to provide effective relief for patients suffering from symptoms of moderate to severe dry eye by forming a protective layer on the eye surface. It offers long-term hydration and supports corneal healing after erosion, trauma, burns, or surgery.
Together, we’re advancing the science of eye care.
